Most cancers at least have the decency to look like something. A mast cell tumor does not. It can pose as a harmless little bump, a fatty lump, an insect bite, or an angry patch of skin. It can swell one day and shrink the next, which fools owners into thinking it is coming and going on its own. That talent for disguise is not a quirk. It is precisely why a mast cell tumor is so dangerous, and why the single most important thing to understand about it is this: you cannot tell what it is by looking, and neither can your vet, without a needle.
Old dogs get lumps. Nearly all of them will grow at least one as they age, and plenty are completely benign, just another gray-muzzle development. The temptation is to write every new bump off as exactly that. Resist it, because mast cell tumors are among the five most frequently diagnosed cancers in dogs, and the sooner one is caught, the more good years you are likely to buy.
What a mast cell actually is
Under normal conditions, mast cells are useful members of the immune system. They respond to inflammation and allergic reactions, and they are packed with granules of histamine, the same compound your own body dumps during hay fever. They live in connective tissue, especially close to the skin’s surface. Trouble starts when these cells begin piling up at one spot instead of doing their patrol work, and that accumulation becomes a tumor.
Mast cell tumors make up roughly 20 percent of canine skin tumors. They tend to be locally invasive, sending roots into surrounding tissue, which is part of why they can be so hard to remove cleanly. For scale, the five canine cancers diagnosed most often are mast cell tumors, lymphoma, melanoma, osteosarcoma, and hemangiosarcoma.
What it looks like, and when the internal alarm should ring
On the outside, a mast cell tumor is simply a lump you can see, feel, or both, and any such lump deserves a check. The more worrying picture is when the disease spreads to internal organs, most often the spleen, liver, or lymph nodes. That is when a dog may start vomiting, having diarrhea, or losing their appetite, because the histamine and other compounds these tumors release can wreak havoc well beyond the skin. Digestive upset in a dog with a known mast cell tumor is not a coincidence to wait out.
The one move that matters: a needle, early
Half of reaching a diagnosis is confirming the lump isn’t a lipoma, the everyday benign fatty growth that develops right under the skin and feels like nothing much. To tell them apart, a vet uses a thin hypodermic needle to draw a sample from the lump. This is fine needle aspiration, and it is fast, relatively inexpensive, and generally well tolerated by the patient. The cells go under a microscope. It is not always definitive; if the sample is too thin or inconclusive, the next step is a biopsy. But that quick, cheap, low-stress needle is the whole ballgame, because it is the only thing that turns a mystery bump into an answer.
Grading tells you how scared to be
Once a mast cell tumor is confirmed, the next question is how aggressive it is. There are two grading systems: the older three-tier Patnaik system and the newer two-tier Kiupel system, which sorts tumors into low grade and high grade.
“The two-tier system was a real step forward, both for predicting how a tumor is going to behave and for getting pathologists to actually agree with each other,” says Dr. Mara Chen. “That agreement matters more than people realize. When two labs read the same slide the same way, you can plan treatment with far more confidence.”
Grading, often combined with imaging like an X-ray or ultrasound and sometimes a bone marrow sample, tells the vet whether the disease is localized to the lump or has gone systemic, which drives everything about treatment. Grade I and II tumors are usually removed surgically, and when caught early and excised along with a broad border of healthy tissue, the outlook is good. Grade II is the frustrating middle child; it may behave like a docile grade I or like a malignant grade III, so it demands judgment. Grade III tumors are always removed.
Treatment, from the operating table to a plant-derived injection
The underlying goal of treatment is to shut down mast cell metabolism so the tumor stops growing and spreading. Vets commonly reach for corticosteroids such as prednisone, which given orally can shrink a mast cell tumor much the way steroids calm a human allergy flare. A related steroid, triamcinolone, can be injected directly into the tumor at several points to reduce its size before surgery.
Surgery is often followed by another therapy, most commonly radiation, which is used more often than chemotherapy for these tumors. Chemotherapy is generally held back for grade III cases, where the response is unpredictable. Some dogs need a second, more aggressive operation. And because a dog who has grown one mast cell tumor tends to grow more, this is a diagnosis that calls for lifelong vigilance, not a one-and-done.
There is also a nonsurgical option for the right tumor. For a non-metastatic, skin-based mast cell tumor, an injection of tigilanol tiglate, a compound extracted from Australia’s blushwood tree, can trigger the rapid destruction of the tumor’s mast cells within about seven days. It can spare a dog from surgery, though it leaves behind a wound that has to be managed as it heals.
Finally, some drugs developed for people may help dogs, because mast cell tumors affect humans too. Two stand out: toceranib phosphate, sold as Palladia and the first tyrosine-kinase inhibitor the FDA cleared for these tumors in dogs, and masitinib (Masivet). Both can help manage the disease and slow its progression with relatively little harm to the dog.
What newer research adds
That plant-derived injection now has a name you can ask your vet about directly: Stelfonta. Tigilanol tiglate was approved by the FDA in November 2020, and the numbers behind it are better than most owners expect. Clinical data show it clears roughly 75 percent of treated mast cell tumors after a single injection, and about 87 percent after one or two treatments combined. Its approval also extends beyond skin tumors to certain non-metastatic subcutaneous mast cell tumors located on a dog’s leg. The drug’s promise isn’t confined to dogs, either; in early 2024, the FDA granted tigilanol tiglate an Orphan Drug Designation for treating a form of soft-tissue sarcoma in humans, a sign of how seriously the underlying compound is being studied.
None of this changes the core lesson. The fanciest injection in the world only helps if the tumor is found early, while it is still small and local. And a mast cell tumor will not tell you it is there. So the takeaway is unglamorous and lifesaving: on an aging dog, treat every new or changing lump as a reason to book a fine needle aspiration, not a reason to wait and see.
References
- U.S. Food and Drug Administration. FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs.
- Musser ML, et al. Response to tigilanol tiglate in dogs with mast cell tumors. Journal of Veterinary Internal Medicine, 2024.
- Kiupel M, et al. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors. Veterinary Pathology, 2011.
- Morris Animal Foundation. Mast Cell Tumors in Dogs.
Mast cell tumors are a medical topic; this article is general information, not a substitute for veterinary diagnosis or care. Have any new or changing lump evaluated by your veterinarian.
